Clinical Trials Browser

NIH × Camurati-Engelmann Syndrome × Breast × Clear all

NCT00001378 2008-03-04

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Phase 1 Completed

Breast Neoplasms, Camurati-Engelmann Syndrome